K2 HealthVentures
Ken Tang, CFA is an experienced finance professional with a robust background in investment banking and healthcare venture capital. Currently serving as Principal at K2 HealthVentures since 2021, Ken previously held the position of Vice President at OrbiMed from 2015 to 2021. Prior roles include Associate positions in Leveraged and Acquisition Finance at HSBC and Investment Banking at Standard Chartered Bank, as well as being an Analyst at Goldman Sachs. Ken began the career with a Summer Analyst role at Deutsche Asset Management. Ken earned a Bachelor of Science degree in Electrical Engineering from Columbia University in 2007.
This person is not in the org chart
This person is not in any offices
K2 HealthVentures
K2 HealthVentures (K2HV) is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. We are healthcare specialists with deep domain expertise, and we understand both the opportunities and challenges that face venture-stage and growth-stage companies. Further, our flat organizational set-up enables nimble decision-making, and our evergreen fund structure allows us to be creative and adapt our facilities to a company’s specific needs over both the short and the long term. Over the last 4 years we have committed more than $1 billion in debt and equity capital to both private and public companies, and our team’s track record spans decades of investing in and supporting innovative life sciences and healthcare companies (with over $4 billion total investments in over 100 portfolio companies).